Scholarlink

<p>Traumatic brain injury (TBI) triggers a cascade of secondary pathophysiological events, including blood-brain barrier (BBB) disruption, intracerebral hemorrhage, neuroinflammation, neuronal death, and persistent neurological deficits. Although transient receptor potential melastatin 7 (TRPM7) is known to regulate cellular stress responses, its role in TBI-induced vascular dysfunction remains unclear. This study aimed to investigate the involvement of TRPM7 in BBB damage and hemorrhage after TBI and to evaluate the therapeutic potential of carvacrol, a TRPM7 inhibitor. TBI was induced in male mice using a controlled cortical impact model. Carvacrol (50&#xa0;mg/kg, i.p.) was administered immediately and 8&#xa0;h post-injury, then once daily for 7 days. In this model, TBI caused marked BBB disruption and cortical and hippocampal hemorrhage, accompanied by increased TRPM7 and JMJD3 expression, matrix metalloproteinase (MMP) activation, SUR1/TRPM4 upregulation, and motor and cognitive deficits. Carvacrol treatment significantly attenuated BBB disruption and hemorrhage, preserved tight junction proteins, and reduced the expression of MMP-3 and MMP-9, and SUR1/TRPM4–known contributor to post-TBI hemorrhage–<i>in vivo</i> and <i>in vitro</i>. Mechanistically, carvacrol inhibited JMJD3 expression and activity, thereby limiting the recruitment of JMJD3 and NF-κB p65 to the promoters of MMP-3, MMP-9, Abcc8, and TRPM4. Behaviorally, carvacrol improved neurological scores, motor performance, and cognitive function after TBI. These findings identify TRPM7 as a key mediator of BBB disruption and hemorrhage the JMJD3–MMP–SUR1/TRPM4 axis after TBI and suggest that targeting TRPM7 may represent a promising strategy for mitigating TBI-associated vascular damage and neurological dysfunction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Carvacrol improves neurological function by inhibiting TRPM7-mediated BBB disruption and hemorrhage after TBI

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Chan Sol Park,
  • Jee Youn Lee,
  • Youngmin Bu,
  • Tae Young Yune

摘要

Traumatic brain injury (TBI) triggers a cascade of secondary pathophysiological events, including blood-brain barrier (BBB) disruption, intracerebral hemorrhage, neuroinflammation, neuronal death, and persistent neurological deficits. Although transient receptor potential melastatin 7 (TRPM7) is known to regulate cellular stress responses, its role in TBI-induced vascular dysfunction remains unclear. This study aimed to investigate the involvement of TRPM7 in BBB damage and hemorrhage after TBI and to evaluate the therapeutic potential of carvacrol, a TRPM7 inhibitor. TBI was induced in male mice using a controlled cortical impact model. Carvacrol (50 mg/kg, i.p.) was administered immediately and 8 h post-injury, then once daily for 7 days. In this model, TBI caused marked BBB disruption and cortical and hippocampal hemorrhage, accompanied by increased TRPM7 and JMJD3 expression, matrix metalloproteinase (MMP) activation, SUR1/TRPM4 upregulation, and motor and cognitive deficits. Carvacrol treatment significantly attenuated BBB disruption and hemorrhage, preserved tight junction proteins, and reduced the expression of MMP-3 and MMP-9, and SUR1/TRPM4–known contributor to post-TBI hemorrhage–in vivo and in vitro. Mechanistically, carvacrol inhibited JMJD3 expression and activity, thereby limiting the recruitment of JMJD3 and NF-κB p65 to the promoters of MMP-3, MMP-9, Abcc8, and TRPM4. Behaviorally, carvacrol improved neurological scores, motor performance, and cognitive function after TBI. These findings identify TRPM7 as a key mediator of BBB disruption and hemorrhage the JMJD3–MMP–SUR1/TRPM4 axis after TBI and suggest that targeting TRPM7 may represent a promising strategy for mitigating TBI-associated vascular damage and neurological dysfunction.